Erratum: In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells (PLoS ONE (2020) 15:11 (e0240020) DOI: 10.1371/journal.pone.0240020)

1Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The images for Fig 5A and 5B are incorrectly switched. The image that appears as Fig 5A should be Fig 5B, and the image that appears as Fig 5B should be Fig 5A. The figure captions appear in the correct order. In Fig 5A and 5B, the signs for statistical significance (** and ***) were missing. Please see the correct figures here. In Fig 7, the word “survivin” in the upper right blue box should appear as “p-survivin”. Please see the correct figure here. (Figure Presented).

Cite

CITATION STYLE

APA

Wanandi, S. I., Limanto, A., Yunita, E., Syahrani, R. A., Louisa, M., Wibowo, A. E., & Arumsari, S. (2021, February 1). Erratum: In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells (PLoS ONE (2020) 15:11 (e0240020) DOI: 10.1371/journal.pone.0240020). PLoS ONE. Public Library of Science. https://doi.org/10.1371/journal.pone.0247694

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free